Acne in recipients of renal transplantation treated with sirolimus: Clinical, microbiologic, histologic, therapeutic, and pathogenic aspects
- 1 July 2006
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 55 (1) , 139-142
- https://doi.org/10.1016/j.jaad.2005.11.1072
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositisJournal of the American Academy of Dermatology, 2005
- Long-Term Benefits with Sirolimus-Based Therapy after Early Cyclosporine WithdrawalJournal of the American Society of Nephrology, 2004
- A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipientsTransplantation, 2003
- Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experienceTransplantation Proceedings, 2003
- Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantationTransplantation Proceedings, 2003
- Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trialBritish Journal of Dermatology, 2001
- A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTSTransplantation, 2001
- Rapamycin in transplantation: A review of the evidenceKidney International, 2001
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyThe Lancet, 2000
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999